Difference between revisions of "Aop:28"

From AOP-Wiki
Jump to: navigation, search
(Migrating page to new template)
 
(16 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
 +
= Status =
 +
<span style="color:#FF0000">
 +
This is a legacy representation of this AOP. Please see the current version here:
  
{{#widget:Revisions}}
+
[//{{SERVERNAME}}/aops/28 https://{{SERVERNAME}}/aops/28]
{{#widget:Network}}
+
</span>
 
+
 
+
 
+
__NOTOC__
+
 
+
  
  
Line 13: Line 11:
  
 
<div class='Title'> Cyclooxygenase inhibition leading reproductive failure </div>
 
<div class='Title'> Cyclooxygenase inhibition leading reproductive failure </div>
 
  
 
<div id='shortTitle' class='Title2'>Short name: Cyclooxygenase inhibition leading reproductive failure </div>
 
<div id='shortTitle' class='Title2'>Short name: Cyclooxygenase inhibition leading reproductive failure </div>
  
 
== Authors ==
 
== Authors ==
 +
Dan Villeneuve, US EPA Mid-Continent Ecology Division (villeneuve.dan@epa.gov)
  
 
== Status ==
 
== Status ==
 +
 +
'''Please follow the link to [//{{SERVERNAME}}/aops/{{PAGENAMEE}}/snapshots snapshots page] to view and create Snapshots of this AOP.'''
 +
 
'''Alert: The Weight of Evidence column in the Molecular Initiating Event and Key Event tables has changed to Essentiality. Consider re-evaluating the columns in these tables.'''
 
'''Alert: The Weight of Evidence column in the Molecular Initiating Event and Key Event tables has changed to Essentiality. Consider re-evaluating the columns in these tables.'''
  
 
'''Under development:  Do not distribute or cite.'''
 
'''Under development:  Do not distribute or cite.'''
  
Putative AOP - under development for International Workshop on Advancing AOPs for Integrated Toxicology and Regulatory Applications
+
Putative AOP
 +
 
 +
'''Project 1.29''': A catalog of putative AOPs that will enhance the utility of US EPA Toxcast high throughput screening data for hazard identification
 +
 
 +
 
 +
This AOP page was last modified on {{REVISIONMONTH1}}/{{REVISIONDAY}}/{{REVISIONYEAR}}.
 +
 
 +
<span id='ToggleRevision' style="text-decoration: underline;">Click here to show/hide revision dates for related pages</span>
 +
{|class="wikitable sortable" id="Revtable"
 +
 
 +
!Page
 +
!Revision Date/Time
 +
 
 +
|-
 +
 
 +
|}
  
 
==  Abstract      ==
 
==  Abstract      ==
Line 30: Line 46:
 
== Summary of the AOP ==
 
== Summary of the AOP ==
 
[[Category:Adverse Outcome Pathway]]
 
[[Category:Adverse Outcome Pathway]]
 +
Please follow link to [//{{SERVERNAME}}/aops/{{PAGENAMEE}} widget page] to edit this section.
 +
 +
<span style="color:#FF0000">'''If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.'''</span>
  
 
=== Molecular Initiating Event ===
 
=== Molecular Initiating Event ===
  
 
<div id="popbox3" title='Add a Record' style='display:none'>
 
 
</div>
 
 
{|class="wikitable sortable" id="MIEproof"
 
{|class="wikitable sortable" id="MIEproof"
  
Line 44: Line 59:
 
|-
 
|-
  
|[[Cyclooxygenase activity, Inhibition]]||||
+
|[[Event:79|Cyclooxygenase activity, Inhibition]]||
  
 
|-
 
|-
Line 52: Line 67:
 
=== Key Events ===
 
=== Key Events ===
  
 
<div id="popbox4" title='Add a Record' style='display:none'>
 
 
</div>
 
 
{|class="wikitable sortable" id="KEproof"
 
{|class="wikitable sortable" id="KEproof"
  
Line 63: Line 74:
 
|-
 
|-
  
|[[Prostaglandin E2 concentration, Reduction]]||||
+
|[[Event:243|Prostaglandin E2 concentration, Reduction]]||
  
 
|-
 
|-
  
|[[Ca and HCO3 transport to shell gland, Reduction]]||||
+
|[[Event:49|Ca and HCO3 transport to shell gland, Reduction]]||
  
 
|-
 
|-
  
|[[Eggshell thickness, Reduction]]||||
+
|[[Event:106|Eggshell thickness, Reduction]]||
  
 
|-
 
|-
  
|[[Reproductive failure, N/A]]||||
+
|[[Event:119|Gap, N/A]]||
 
+
|-
+
 
+
|[[Gap, N/A]]||||
+
  
 
|-
 
|-
Line 87: Line 94:
 
=== Adverse Outcome ===
 
=== Adverse Outcome ===
  
 
<div id="popbox5" title='Add a Record' style='display:none'>
 
 
</div>
 
 
{|class="wikitable sortable" id="AOproof"
 
{|class="wikitable sortable" id="AOproof"
  
Line 97: Line 100:
 
|-
 
|-
  
|[[Reproduction, failure]]||
+
|[[Event:253|Reproductive failure, N/A]]
  
 
|-
 
|-
Line 105: Line 108:
 
=== Relationships Among Key Events and the Adverse Outcome ===
 
=== Relationships Among Key Events and the Adverse Outcome ===
  
 
<div id="popbox" title='Add a Record' style='display:none'>
 
 
</div>
 
 
{| class="wikitable sortable" id="relation"
 
{| class="wikitable sortable" id="relation"
  
!Step
 
 
!Event
 
!Event
 
!Description
 
!Description
Line 120: Line 118:
 
|-
 
|-
  
|1||[[Cyclooxygenase activity, Inhibition]]||[[Cyclooxygenase activity, Inhibition Relating to Prostaglandin E2 concentration, Reduction|Directly Leads to]]||[[Prostaglandin E2 concentration, Reduction]]||[[Cyclooxygenase activity, Inhibition Relating to Prostaglandin E2 concentration, Reduction#Biological Plausibility|Moderate]]||||
+
|[[Event:79|Cyclooxygenase activity, Inhibition]]||[[Relationship:95|Directly Leads to]]||[[Event:243|Prostaglandin E2 concentration, Reduction]]||[[Relationship:95#Weight of Evidence|Moderate]]||
  
 
|-
 
|-
  
|2||[[Prostaglandin E2 concentration, Reduction]]||[[Prostaglandin E2 concentration, Reduction Relating to Gap, N/A|Directly Leads to]]||[[Gap, N/A]]||[[Prostaglandin E2 concentration, Reduction Relating to Gap, N/A#Biological Plausibility|Not Specified]]||||
+
|[[Event:243|Prostaglandin E2 concentration, Reduction]]||[[Relationship:268|Directly Leads to]]||[[Event:119|Gap, N/A]]||[[Relationship:268#Weight of Evidence|Not Specified]]||
  
 
|-
 
|-
  
|3||[[Gap, N/A]]||[[Gap, N/A Relating to Ca and HCO3 transport to shell gland, Reduction|Directly Leads to]]||[[Ca and HCO3 transport to shell gland, Reduction]]||[[Gap, N/A Relating to Ca and HCO3 transport to shell gland, Reduction#Biological Plausibility|Not Specified]]||||
+
|[[Event:119|Gap, N/A]]||[[Relationship:136|Directly Leads to]]||[[Event:49|Ca and HCO3 transport to shell gland, Reduction]]||[[Relationship:136#Weight of Evidence|Not Specified]]||
  
 
|-
 
|-
  
|4||[[Ca and HCO3 transport to shell gland, Reduction]]||[[Ca and HCO3 transport to shell gland, Reduction Relating to Eggshell thickness, Reduction|Directly Leads to]]||[[Eggshell thickness, Reduction]]||[[Ca and HCO3 transport to shell gland, Reduction Relating to Eggshell thickness, Reduction#Biological Plausibility|Moderate]]||||
+
|[[Event:49|Ca and HCO3 transport to shell gland, Reduction]]||[[Relationship:59|Directly Leads to]]||[[Event:106|Eggshell thickness, Reduction]]||[[Relationship:59#Weight of Evidence|Moderate]]||
  
 
|-
 
|-
  
|5||[[Eggshell thickness, Reduction]]||[[Eggshell thickness, Reduction Relating to Reproductive failure, N/A|Directly Leads to]]||[[Reproductive failure, N/A]]||[[Eggshell thickness, Reduction Relating to Reproductive failure, N/A#Biological Plausibility|Strong]]||||
+
|[[Event:106|Eggshell thickness, Reduction]]||[[Relationship:123|Directly Leads to]]||[[Event:253|Reproductive failure, N/A]]||[[Relationship:123#Weight of Evidence|Strong]]||
  
 
|-
 
|-
Line 152: Line 150:
 
=== Life Stage Applicability ===
 
=== Life Stage Applicability ===
  
 
<div id="popbox1" title='Add a Record' style='display:none'>
 
 
</div>
 
 
{|class="wikitable sortable" id="LSproof"
 
{|class="wikitable sortable" id="LSproof"
  
Line 167: Line 161:
  
 
=== Taxonomic Applicability ===
 
=== Taxonomic Applicability ===
 
 
<div id="popbox6" title='Add a Record' style='display:none'>
 
 
</div>
 
 
<div id="hideMsg" style='display:none'>
 
Attempting to compile scientific names.
 
This box will close when the task is complete.
 
Process time: <span>0</span>
 
</div>
 
  
 
{|class="wikitable sortable" id="Specproof"
 
{|class="wikitable sortable" id="Specproof"
Line 192: Line 175:
 
=== Sex Applicability ===
 
=== Sex Applicability ===
  
 
<div id="popbox2" title='Add a Record' style='display:none'>
 
 
</div>
 
 
{|class="wikitable sortable" id="Sexproof"
 
{|class="wikitable sortable" id="Sexproof"
  
Line 208: Line 187:
 
=== Graphical Representation ===
 
=== Graphical Representation ===
  
*[http://aopwiki.org/common/AOP_Graphic_Template2.pptx Click to download template for graphical representation]
+
*[https://aopkb.org/common/AOP_Graphic_Template2.pptx Click to download template for graphical representation]
  
 
[[File:Cyclooxygenase inhibition leading reproductive failure.jpg | 900px | Click to upload graphical representation]]
 
[[File:Cyclooxygenase inhibition leading reproductive failure.jpg | 900px | Click to upload graphical representation]]

Latest revision as of 18:39, 11 December 2016

Status

This is a legacy representation of this AOP. Please see the current version here:

https://aopwiki.org/aops/28


AOP Title

Cyclooxygenase inhibition leading reproductive failure
Short name: Cyclooxygenase inhibition leading reproductive failure

Authors

Dan Villeneuve, US EPA Mid-Continent Ecology Division (villeneuve.dan@epa.gov)

Status

Please follow the link to snapshots page to view and create Snapshots of this AOP.

Alert: The Weight of Evidence column in the Molecular Initiating Event and Key Event tables has changed to Essentiality. Consider re-evaluating the columns in these tables.

Under development: Do not distribute or cite.

Putative AOP

Project 1.29: A catalog of putative AOPs that will enhance the utility of US EPA Toxcast high throughput screening data for hazard identification


This AOP page was last modified on 12/11/2016.

Click here to show/hide revision dates for related pages

Page Revision Date/Time

Abstract

Summary of the AOP

Please follow link to widget page to edit this section.

If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.

Molecular Initiating Event

Molecular Initiating Event Support for Essentiality
Cyclooxygenase activity, Inhibition

Key Events

Event Support for Essentiality
Prostaglandin E2 concentration, Reduction
Ca and HCO3 transport to shell gland, Reduction
Eggshell thickness, Reduction
Gap, N/A

Adverse Outcome

Adverse Outcome
Reproductive failure, N/A

Relationships Among Key Events and the Adverse Outcome

Event Description Triggers Weight of Evidence Quantitative Understanding
Cyclooxygenase activity, Inhibition Directly Leads to Prostaglandin E2 concentration, Reduction Moderate
Prostaglandin E2 concentration, Reduction Directly Leads to Gap, N/A Not Specified
Gap, N/A Directly Leads to Ca and HCO3 transport to shell gland, Reduction Not Specified
Ca and HCO3 transport to shell gland, Reduction Directly Leads to Eggshell thickness, Reduction Moderate
Eggshell thickness, Reduction Directly Leads to Reproductive failure, N/A Strong

Network View

   Cytoscape Web will replace the contents of this div with your graph.

Click nodes or edges.

Life Stage Applicability

Life Stage Evidence Links

Taxonomic Applicability

Name Scientific Name Evidence Links

Sex Applicability

Sex Evidence Links

Graphical Representation

Click to upload graphical representation

Overall Assessment of the AOP

Consider the following criteria (may include references to KE Relationship pages): 1. concordance of dose-response relationships; 2. temporal concordance among the key events and adverse effect; 3. strength, consistency, and specificity of association of adverse effect and initiating event; 4. biological plausibility, coherence, and consistency of the experimental evidence; 5. alternative mechanisms that logically present themselves and the extent to which they may distract from the postulated AOP. It should be noted that alternative mechanisms of action, if supported, require a separate AOP; 6. uncertainties, inconsistencies and data gaps.

Weight of Evidence Summary

Summary Table
Provide an overall summary of the weight of evidence based on the evaluations of the individual linkages from the Key Event Relationship pages.

Essentiality of the Key Events

Molecular Initiating Event Summary, Key Event Summary
Provide an overall assessment of the essentiality for the key events in the AOP. Support calls for individual key events can be included in the molecular initiating event, key event, and adverse outcome tables above.

Quantitative Considerations

Summary Table
Provide an overall discussion of the quantitative information available for this AOP. Support calls for the individual relationships can be included in the Key Event Relationship table above.

Applicability of the AOP

Life Stage Applicability, Taxonomic Applicability, Sex Applicability
Elaborate on the domains of applicability listed in the summary section above. Specifically, provide the literature supporting, or excluding, certain domains.

Considerations for Potential Applications of the AOP (optional)

References